Who are Canopy Biosciences's investors?

Canopy Biosciences's investors include Ampersand, BioGenerator Ventures.

How much funding has Canopy Biosciences raised?

Canopy Biosciences has disclosed $3.2M raised across 2 rounds.

Where is Canopy Biosciences headquartered?

Canopy Biosciences is headquartered in Saint Louis, US.

Canopy Biosciences

Saint Louis, US · Founded 2016 · Delaware LLC · 319 employees on LinkedIn · 2 known investors

Find your way into Canopy Biosciences

709 people in our graph share verified history with the Canopy Biosciences team — schools, employers, funds. One of them is your warm intro.

Adam Valkinunlockedknows Edward Weinstein · together at Harvard University (overlapped)

×3knows the team · via University of Michigan

×6knows the team · via Harvard University

×2knows the team · via Merck

Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples. The company serves research institutions, academic medical centers, and clinical laboratories studying oncology, biomarker discovery, and disease mechanisms.

Biotech Healthtech Medical Devices

Founders & leadership

EDWARD WEINSTEIN inPresident and CEO2016–2022Edward Weinstein has over twenty years of experience in life sciences leadership, including previous work at Panome Bio. He brings expertise in genetic engineering and personalized medicine.

CRYSTAL WINKELERChief Operating OfficerManaging Director at BioGenerator Ventures

CHARLES BOLTENNamed on SEC filing

DAVID KINGSLEYNamed on SEC filing

Board

DAVID SMOLLER inBoard directorGeneral Partner at Cultivation Capital

Investors · 2

AmpersandBoston

BioGenerator VenturesSt. Louis · $50K – $250K

Reported raises · per SEC filings

Form D private placements

$3.2M disclosed across 2 rounds · 2016–2017

▶$2.1MraisedJan 2018 · 16 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

CHARLES BOLTENDirector
CRYSTAL WINKELERExecutive Officer
EDWARD WEINSTEINExecutive Officer, Director
DAVID SMOLLERDirector
DAVID KINGSLEYDirector

Offering amount: $3.4M
Amount sold: $2.1M
Minimum investment: $20K
First sale: Dec 2017
Incorporated: Limited Liability Company, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.1MraisedJul 2017 · 15 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

EDWARD WEINSTEINExecutive Officer, Director
DAVID SMOLLERDirector
CRYSTAL WINKELERExecutive Officer
CHARLES BOLTENDirector
DAVID KINGSLEYDirector

Offering amount: $1.1M
Amount sold: $1.1M
Minimum investment: $20K
First sale: Oct 2016
Incorporated: Limited Liability Company, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Canopy Biosciences went on to found or lead other companies.

David SmollerDirectorFounded Panome Bio +1 Edward WeinsteinPresident and CEOFounded Panome Bio

In the news

Gene editing startup Canopy Biosciences raises $2.4 million in Series A financing to advance the development of research tools - Tech Startupstechstartups.com · May 2018

Canopy Biosciences Closes $2.4M Series A Funding - FinSMEsfinsmes.com · May 2018

Frequently asked questions

What does Canopy Biosciences do?: Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples. The company serves research institutions, academic medical centers, and clinical laboratories studying oncology, biomarker discovery, and disease mechanisms.
Who are Canopy Biosciences's investors?: Canopy Biosciences's investors include Ampersand, BioGenerator Ventures.
How much funding has Canopy Biosciences raised?: Canopy Biosciences has disclosed $3.2M raised across 2 rounds.
Where is Canopy Biosciences headquartered?: Canopy Biosciences is headquartered in Saint Louis, US.